Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
In this article we will analyze whether LogicBio Therapeutics, Inc.
Logicbio Therapeutics Inc. (LOGC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 0 | $0 | 0% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 0 | $0 | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.00 | 296,296 | Large Shareholder, Director | 296,296 | 2020-10-01 | Filing | |
| $6.00 | 639,212 | Large Shareholder, Director | 4,126,972 | 2020-10-01 | Filing | |
| $6.00 | 545,974 | Large Shareholder, Director | 3,524,997 | 2020-10-01 | Filing | |
| $6.00 | 296,296 | Large Shareholder, Director | 296,296 | 2020-10-01 | Filing | |
| $6.00 | 639,212 | Large Shareholder, Director | 4,126,972 | 2020-10-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.35 | 1,467 | Officer | 3,331 | 2021-08-09 | Filing | |
| $5.73 | 2,977 | Officer | 23,387 | 2021-04-16 | Filing | |
| $5.73 | 7,542 | Officer, Director | 253,811 | 2021-04-16 | Filing | |
| $7.54 | 273,584 | Large Shareholder | 2,381,436 | 2020-09-28 | Filing | |
| $7.08 | 174,219 | Large Shareholder | 2,655,020 | 2020-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is LogicBio Therapeutics, Inc. (LOGC) Going to Burn These Hedge Funds?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Cutting Exposure To LogicBio Therapeutics, Inc. (LOGC)
In this article we will take a look at whether hedge funds think LogicBio Therapeutics, Inc. (NASDAQ:LOGC) is a good investment right now.
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.